Imugene to commence new phase 2 PD1-Vaxx bowel cancer trial

By Proactive Investors / December 06, 2023 / www.youtube.com / Article Link

Imugene Ltd (ASX:IMU, OTC:IUGNF) CEO Leslie Chong tells Proactive the company is preparing 10 clinical trial sites in Australia ...

Recent News

Metals far outpacing tech over past year

February 09, 2026 / www.canadianminingreport.com

Gold stocks gain on metal recovery

February 09, 2026 / www.canadianminingreport.com

Immediate trigger for crash was new Fed Chairman pick

February 02, 2026 / www.canadianminingreport.com

Gold stocks slump on metal price decline

February 02, 2026 / www.canadianminingreport.com

Is the gold market starting to turn 'irrationally exuberant'?

January 26, 2026 / www.canadianminingreport.com

See all >